6-(1-piperidyl)-7H-dibenzo[b,e][1,4]diazepine
ADVERTISEMENT
- Molecular formula
- C16H18N4
- IUPAC Name
- 6-(1-piperidyl)-7H-benzo[d][1,3]benzodiazepine
- Molecular Weight
- 262.34g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1300g/cm3
- Synonyms
- BRN 0664740
Identification
Interesting facts
Interesting Facts about 6-(1-piperidyl)-7H-benzo[d][1,3]benzodiazepine
6-(1-piperidyl)-7H-benzo[d][1,3]benzodiazepine is a fascinating chemical compound that belongs to the class of benzodiazepines, which are well-known for their usage in therapeutics and pharmacology. Here are some intriguing aspects of this compound:
- Mechanism of Action: As a benzodiazepine, this compound typically interacts with the GABAA receptor in the brain, enhancing the inhibitory effect of GABA, a neurotransmitter. This interaction leads to a calming effect on the central nervous system.
- Potential Therapeutic Uses: Compounds in this class may be explored for their applications in treating anxiety, insomnia, and various disorders associated with neurotransmitter imbalances.
- Structural Complexity: The unique structure of 6-(1-piperidyl)-7H-benzo[d][1,3]benzodiazepine, featuring a piperidine group, contributes to its pharmacological properties. The presence of these functional groups allows for specific interactions with various biological targets.
- Scientific Interest: Researchers are continually studying this compound to expand our understanding of benzodiazepines and discover new derivatives that may have improved efficacy or reduced side effects.
- Safety Profile: Like other benzodiazepines, this compound may have risks associated with dependence and withdrawal. Understanding these aspects is crucial for ongoing research and clinical applications.
In summary, 6-(1-piperidyl)-7H-benzo[d][1,3]benzodiazepine exemplifies the intricate relationship between structure and function in pharmacology. As research continues to unveil its potential, it remains a significant subject of interest for both scientists and healthcare practitioners alike.